Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FS2 versus manual compression for surgical haemostasis in PTFE vascular graft procedures
2005-000889-39Phase 3Completed
- Sponsor
- OMRIX Biopharmaceuticals, Inc.
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of porcine fibrin sealant in Bleeding, peripheral artery occlusion (PAD) and chronic kidney disease (CKD) (2 arms), sponsored by OMRIX Biopharmaceuticals, Inc. Started May 2005; status: completed.
02
Drugs
porcine fibrin sealant
03
Conditions
Bleedingperipheral artery occlusion (PAD)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-000889-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000889-39.